Eugene Schneider, the EVP of $IONS, sold 9,549 shares of the company on 08-04-2025 for an estimated $408,701. We received data on the trade from a recent SEC filing. This was a sale of approximately 15.6% of their shares of this class of stock. Following this trade, they now own 51,507 shares of this class of $IONS stock.
$IONS Insider Trading Activity
$IONS insiders have traded $IONS stock on the open market 11 times in the past 6 months. Of those trades, 1 have been purchases and 10 have been sales.
Here’s a breakdown of recent trading of $IONS stock by insiders over the last 6 months:
- BRETT P MONIA (Chief Executive Officer) has made 0 purchases and 4 sales selling 42,575 shares for an estimated $1,391,843.
- MICHAEL R HAYDEN purchased 15,000 shares for an estimated $477,900
- EUGENE SCHNEIDER (EVP, Chf Clinical Develop Ofcr) sold 9,549 shares for an estimated $408,701
- PATRICK R. O'NEIL (EVP CLO & General Counsel) has made 0 purchases and 2 sales selling 7,372 shares for an estimated $233,985.
- JOSEPH BAROLDI (EVP, Chief Business Officer) sold 3,928 shares for an estimated $111,555
- KYLE JENNE (EVP, Chf GL Pdt Str Ofcr) sold 3,016 shares for an estimated $85,533
- BRIAN BIRCHLER (EVP, Corp and Development Ops) sold 680 shares for an estimated $19,291
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$IONS Hedge Fund Activity
We have seen 155 institutional investors add shares of $IONS stock to their portfolio, and 193 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- DEEP TRACK CAPITAL, LP added 2,630,279 shares (+136.0%) to their portfolio in Q1 2025, for an estimated $79,355,517
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. added 2,006,334 shares (+14.2%) to their portfolio in Q1 2025, for an estimated $60,531,096
- BVF INC/IL added 1,913,385 shares (+inf%) to their portfolio in Q1 2025, for an estimated $57,726,825
- CLEARBRIDGE INVESTMENTS, LLC removed 1,618,220 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $48,821,697
- CITADEL ADVISORS LLC added 1,314,146 shares (+60.7%) to their portfolio in Q1 2025, for an estimated $39,647,784
- FMR LLC added 924,094 shares (+4.1%) to their portfolio in Q1 2025, for an estimated $27,879,915
- CAPITAL WORLD INVESTORS added 896,581 shares (+7.8%) to their portfolio in Q1 2025, for an estimated $27,049,848
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$IONS Analyst Ratings
Wall Street analysts have issued reports on $IONS in the last several months. We have seen 8 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Raymond James issued a "Strong Buy" rating on 07/31/2025
- HC Wainwright & Co. issued a "Buy" rating on 07/31/2025
- Morgan Stanley issued a "Overweight" rating on 07/31/2025
- Barclays issued a "Overweight" rating on 07/01/2025
- Guggenheim issued a "Buy" rating on 05/01/2025
- Needham issued a "Buy" rating on 04/30/2025
- Citigroup issued a "Buy" rating on 02/20/2025
To track analyst ratings and price targets for $IONS, check out Quiver Quantitative's $IONS forecast page.
$IONS Price Targets
Multiple analysts have issued price targets for $IONS recently. We have seen 11 analysts offer price targets for $IONS in the last 6 months, with a median target of $62.0.
Here are some recent targets:
- Gary Nachman from Raymond James set a target price of $64.0 on 07/31/2025
- Michael Ulz from Morgan Stanley set a target price of $62.0 on 07/31/2025
- Mitchell Kapoor from HC Wainwright & Co. set a target price of $65.0 on 07/31/2025
- Gena Wang from Barclays set a target price of $57.0 on 07/01/2025
- Jessica Fye from JP Morgan set a target price of $48.0 on 06/12/2025
- Debjit Chattopadhyay from Guggenheim set a target price of $64.0 on 05/01/2025
- Joseph Stringer from Needham set a target price of $55.0 on 04/30/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
